Coronary artery disease among patients admitted with atrial fibrillation and chest pain

被引:1
作者
Brezinov, Olga Perelshtein [1 ]
Vorotilina, Natalya
Vasilenko, Lubov
Kogan, Yonatan
Lev, Eli, I
Laish-Farkash, Avishag
机构
[1] Samson Assuta Ashdod Univ MC, Cardiol Dept, 7 Harefua St, IL-7747629 Ashdod, Israel
关键词
atrial fibrillation; coronary artery disease; echocardiography; ischemic heart disease; ST depression; Troponin; ST-SEGMENT DEPRESSION; ASSOCIATION; ISCHEMIA;
D O I
10.1097/MCA.0000000000001206
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
IntroductionPatients who present to the emergency department with chest pain during an episode of atrial fibrillation (AF) impose a clinical challenge regarding the source of pain - being coronary artery disease (CAD) or AF in origin. The aim of this study was to identify clinical, imaging or laboratory markers which can predict significant CAD among patients with an AF episode and chest pain. MethodsWe included 57 consecutive patients admitted to our hospital with AF and chest pain. All patients underwent coronary evaluation. Significant CAD was defined as >50% stenosis in a major coronary artery by coronary angiography or cardiac CT. We compared CAD and non-CAD groups and analyzed risk factorsby regression analysis. ResultsTwenty-four patients (42%) were diagnosed with- and 33 patients (58%) without obstructive CAD. In a multivariate analysis of regional wall motion abnormality (RWMA), elevated troponin and hypertension were found to be predictors for CAD [odds ratio (OR), 22.4 (confidence interval (CI), 1.8-272.4; P = 0.02); OR, 5.6 (CI, 1-31.0; P = 0.05) and OR, 21.4 (CI, 1.6-284.6; P = 0.02), respectively]. There were no significant differences regarding the rate of typical chest pain at presentation in the CAD vs. the non-CAD group [13 (54%) vs. 20 (60%), P = 0.374], or in ECG ST-changes [12 (50%) vs.9 (27%), respectively; P = 0.08]. ConclusionIn patients who present acutely with chest pain and AF, troponin elevation and RWMA appear to be highly predictive of obstructive CAD, whereas clinical symptoms and ECG changes are not predictive. These findings may be helpful for guiding the management of patients admitted with AF and chest pain.
引用
收藏
页码:96 / 101
页数:6
相关论文
共 50 条
  • [41] Atrial fibrillation and coronary artery disease: An integrative review focusing on therapeutic implications of this relationship
    Batta, Akash
    Hatwal, Juniali
    Batta, Akshey
    Verma, Samman
    Sharma, Yash Paul
    WORLD JOURNAL OF CARDIOLOGY, 2023, 15 (05): : 229 - 243
  • [42] Class 1C antiarrhythmic drugs in atrial fibrillation and coronary artery disease
    Pantlin, Peter G.
    Bober, Robert M.
    Bernard, Michael L.
    Khatib, Sammy
    Polin, Glenn M.
    Rogers, Paul A.
    Morin, Daniel P.
    JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2020, 31 (03) : 607 - 611
  • [43] Predictors of significant coronary artery disease in atrial fibrillation: Are cardiac troponins a useful measure
    Alghamry, Alaa
    Hanna, Joseph
    Pelecanos, Anita
    Kyranis, Stephen
    Khelgi, Vinod
    O'Rourke, Peter
    Carroll, Oran
    Oxenford, Cassie
    Rangaswamaiah, Swetha
    Tan, Christopher
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2016, 223 : 744 - 749
  • [44] Impact of atrial fibrillation on clinical outcomes among patients with coronary artery disease undergoing revascularisation with drug-eluting stents
    Pilgrim, Thomas
    Kalesan, Bindu
    Zanchin, Thomas
    Pulver, Cedric
    Jung, Simon
    Mattle, Heinrich
    Carrel, Thierry
    Moschovitis, Aris
    Stortecky, Stefan
    Wenaweser, Peter
    Stefanini, Giulio G.
    Raeber, Lorenz
    Meier, Bernhard
    Jueni, Peter
    Windecker, Stephan
    EUROINTERVENTION, 2013, 8 (09) : 1061 - 1071
  • [45] Real-world clinical outcomes of oral anticoagulants among Japanese patients with atrial fibrillation and concomitant coronary artery disease
    Chen, Yijiao
    Gong, Xiaoqian
    Bao, Haikun
    IJC HEART & VASCULATURE, 2023, 49
  • [46] Antithrombotic regimens in patients with atrial fibrillation and coronary artery disease after percutaneous coronary intervention: A focused review
    Chang, Kay-Won
    Arbit, Boris
    Hsu, Jonathan C.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2017, 243 : 263 - 269
  • [47] Association of Diagonal Earlobe Crease with Risk of Atrial Fibrillation in Stable Patients with Coronary Artery Disease
    Jin, Moo-Nyun
    Song, Changho
    Kim, Young Ju
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (18)
  • [48] Are Class IC Antiarrhythmic Agents Safe in Atrial Fibrillation Patients With Nonobstructive Coronary Artery Disease?
    Naccarelli, Gerald V.
    JACC-CLINICAL ELECTROPHYSIOLOGY, 2023, 9 (07) : 1181 - 1183
  • [49] Thiazolidinediones and Risk of Atrial Fibrillation Among Patients with Diabetes and Coronary Disease
    Pallisgaard, Jannik Langtved
    Brooks, Maria Mori
    Chaitman, Bernard R.
    Boothroyd, Derek B.
    Pere, Marco
    Hlatk, Mark A.
    AMERICAN JOURNAL OF MEDICINE, 2018, 131 (07) : 805 - 812
  • [50] The effect of antiarrhythmic medications on the risk of cardiovascular outcomes in patients with atrial fibrillation and coronary artery disease
    Wang, Shih-Rong
    Huang, Kuan-Chih
    Lin, Ting-Tse
    Chuang, Shu-Lin
    Yang, Yen-Yun
    Wu, Cho -Kai
    Lin, Lian-Yu
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2024, 409